SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001104659-23-059902
Filing Date
2023-05-12
Accepted
2023-05-12 17:28:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 POS AM tm2315613d1_posam.htm POS AM 634907
2 EXHIBIT 5.1 tm2315613d1_ex5-1.htm EX-5.1 38127
3 EXHIBIT 23.1 tm2315613d1_ex23-1.htm EX-23.1 2319
4 GRAPHIC tm2315613d1_posamsp1img001.jpg GRAPHIC 3360
5 GRAPHIC tm2315613d1_posamimg01.jpg GRAPHIC 10915
6 GRAPHIC tm2315613d1_posamsp4img002.jpg GRAPHIC 3573
7 GRAPHIC tm2315613d1_ex5-1img001.jpg GRAPHIC 4136
8 GRAPHIC tm2315613d1_ex5-1img003.jpg GRAPHIC 4523
9 GRAPHIC tm2315613d1_ex5-1img002.jpg GRAPHIC 3121
  Complete submission text file 0001104659-23-059902.txt   718236
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-261888 | Film No.: 23917207
SIC: 2836 Biological Products, (No Diagnostic Substances)